BGAI
IONS icon

Bruce G. Allen Investments’s Ionis Pharmaceuticals IONS Stock Holding History

Bruce G. Allen Investments’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.73K Hold
23
– – ﹤0.01% 714
2025
Q4 		$1.82K Hold
23
– – ﹤0.01% 712
2025
Q3 		$1.5K Hold
23
– – ﹤0.01% 752
2025
Q2 		$909 Buy
23
+10
+77% +$327 ﹤0.01% 843
2025
Q1 		$392 Buy
+13
New +$426 ﹤0.01% 984

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bruce G. Allen Investments's IONS Position: Q1 2026 in Review

Bruce G. Allen Investments held its Ionis Pharmaceuticals (IONS) position steady in Q1 2026 at 23 shares worth $1.73K. The position accounts for ﹤0.01% of the portfolio, ranked #714.

Bruce G. Allen Investments first reported a position in IONS in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.82K in Q4 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Bruce G. Allen Investments held 23 shares of Ionis Pharmaceuticals worth $1.73K as of Q1 2026.
  • Bruce G. Allen Investments left its Ionis Pharmaceuticals share count unchanged in Q1 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Bruce G. Allen Investments's portfolio in Q1 2026, its #714 holding.
  • Bruce G. Allen Investments first reported a position in Ionis Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Bruce G. Allen Investments's Ionis Pharmaceuticals position peaked at $1.82K in Q4 2025.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Bruce G. Allen Investments's 13F filing for Q1 2026, filed 8 May 2026.